CIK: 1802653 - Address: C/o Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300E, Washington, DC 20037
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/11/23 16:36
8/10/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDS-396.050-7-1829D
6/14/22 20:37
6/13/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDS-269.480-3-297D
9/13/21 16:40
9/9/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDM.d23012.030199D
9/13/21 16:40
9/9/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDS.d-32016.740-19-679D
6/17/21 17:01
6/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDM.d4210.5704779D
6/17/21 17:01
6/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMitchell Stephen RayDCDS.d-9719.420-5-359D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact